WILLIAM H. BEIERWALTES, M.D.
Ten years have now elapsed since the first patient with carcinoma of the thyroid was treated with radioactive iodine.1 More than 250 thyroid carcinoma patients have been treated since then with radioactive iodine, I131.2 Review of the literature and our experience in treating 24 such patients have indicated certain criteria to be of definite value in the selection of patients for I131 therapy. Lack of regard for these criteria has, in our hands, led to wasteful use of I131 and rise of false hopes in the thyroid cancer patient. It is the purpose of this discussion, therefore, to review these
Learn more about subscription options.
Register Now for a free account.
BEIERWALTES WH. INDICATIONS AND CONTRAINDICATIONS FOR TREATMENT OF THYROID CANCER WITH RADIOACTIVE IODINE(INDICATIONS AND CONTRAINDICATIONS FOR TREATMENT OF THYROID CANCER WITH RADIOACTIVE IODINE*). Ann Intern Med. 1952;37:23–30. doi: 10.7326/0003-4819-37-1-23
Download citation file:
Published: Ann Intern Med. 1952;37(1):23-30.
Endocrine and Metabolism, Endocrine Cancer, Hematology/Oncology, Thyroid Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only